Projects per year
Personal profile
Biography
Medicinal Chemistry Theme Leader, Monash Institute of Pharmaceutical Sciences
Associate Dean, Research, Faculty of Pharmacy & Pharmaceutical Sciences
Research interests
- Allosteric modulators and bitopic ligands acting at G protein-coupled receptors
- The design and synthesis of cancer therapeutics based on Noscapine
- New methodology for the preparation of semi-synthetic opioid pharmaceuticals
- The development of M1 and M17 aminopeptidase inhibitors as antimalarial agents
- Applications of ionic liquids in pharmaceutical synthesis and drug delivery
Monash teaching commitment
Bachelor of Pharmaceutical Science:
-
BPS2021 Synthetic Chemistry I: Structure & Reactivity (Unit Coordinator)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Griffith University
Award Date: 2 Apr 1991
B.Sc. (Hons), Griffith University
Award Date: 2 Apr 1986
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Positive allosteric modulation of anti-convulsant G protein-coupled receptor signalling to treat drug-resistant epilepsy
May, L., Webb, G., Carlsson, J., Baltos, J., Nguyen, A., Christopoulos, A., Miao, Y., O'Brien, T., Rollo, B., Casillas-Espinosa, P., Gregory, K., Scammells, P. & Nguyen, T.
1/01/22 → 31/12/25
Project: Research
-
Multidisciplinary catalyst to discover and progress novel antimalarial drugs
Charman, S., Creek, D., de Koning-Ward, T. F., Gilson, P., McGowan, S. & Scammells, P.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/20 → 31/12/24
Project: Research
-
Newcastle University/Monash Academic Track (NUMAcT) scheme
Mann, D. A., Porter, C. & Scammells, P.
1/08/19 → 31/05/25
Project: Other
-
Chemical-Biology Approaches to Pathway Selective Adenosine Receptor Ligands
Scammells, P. & Christopoulos, A.
1/07/19 → 31/12/22
Project: Research
-
Melbourne Biomolecular NMR Network
Stone, M., Bottomley, S., Gooley, P., Langford, S., Reynolds, E. C., Scammells, P., Scanlon, M., Separovic, F., Tuck, K., Whisstock, J. & Wilce, J.
Australian Research Council (ARC), University of Melbourne, Monash University
1/01/09 → …
Project: Research
-
Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy
Wakeham, M. C. L., Davie, B. J., Chalmers, D. K., Christopoulos, A., Capuano, B., Valant, C. & Scammells, P. J., 5 Jan 2022, In: ACS Chemical Neuroscience. 13, 1, p. 97-111 15 p.Research output: Contribution to journal › Article › Research › peer-review
-
1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure
Yong, C., Devine, S. M., Abel, A. C., Tomlins, S. D., Muthiah, D., Gao, X., Callaghan, R., Steinmetz, M. O., Prota, A. E., Capuano, B. & Scammells, P. J., 16 Sep 2021, In: ChemMedChem. 16, 18, p. 2882-2894 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
A Structure−Activity Relationship Study of Novel Hydroxamic Acid Inhibitors around the S1 Subsite of Human Aminopeptidase N
Lee, J., Drinkwater, N., McGowan, S. & Scammells, P., 8 Jan 2021, In: ChemMedChem. 16, 1, p. 234-249 17 p.Research output: Contribution to journal › Article › Research › peer-review
-
Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1Receptor in Living Cells
Comeo, E., Trinh, P., Nguyen, A. T., Nowell, C. J., Kindon, N. D., Soave, M., Stoddart, L. A., White, J. M., Hill, S. J., Kellam, B., Halls, M. L., May, L. T. & Scammells, P. J., 16 Mar 2021, In: Journal of Medicinal Chemistry. 64, 10, p. 6670–6695 26 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
Jörg, M., Khajehali, E., van der Westhuizen, E. T., C. Choy, K. H., Shackleford, D. M., Tobin, A. B., Sexton, P. M., Valant, C., Capuano, B., Christopoulos, A. & Scammells, P. J., 8 Jan 2021, In: ChemMedChem. 16, 1, p. 216-233 18 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)
-
MONASH UNIVERSITY (Organisational unit)
Peter Scammells (Inventor) & Gaik Orbell (Inventor)
14 Apr 2016Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
-
MONASH UNIVERSITY (Organisational unit)
Peter Scammells (Inventor) & Gaik Orbell (Inventor)
3 Aug 2016Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
-
MONASH UNIVERSITY (Organisational unit)
Gaik Orbell (Inventor) & Peter Scammells (Inventor)
7 Jul 2015Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
-
Theme Leader
Peter Scammells (Member)
12 Aug 2013Activity: External Academic Engagement › Grant review responsibilities